Is central stimulant use for ADHD heading in the right direction? Comment 10 February 2013 Pages: 2 - 2
Resources needed to support global efforts to expand HAART access Comment 10 February 2013 Pages: 3 - 3
Cefotaxime, ceftriaxone use improved with web-based approval system Clinical study 10 February 2013 Pages: 4 - 4
Celecoxib, rofecoxib use inconsistent with good clinical practice Clinical study 10 February 2013 Pages: 4 - 4
Cognitive therapy worth it to prevent relapse in depression? Clinical study 10 February 2013 Pages: 4 - 4
Nasal airway treatment worth it in sleep apnoea syndrome? Clinical study 10 February 2013 Pages: 5 - 5
Disparities in diabetes care delivery in Canada and the US Clinical study 10 February 2013 Pages: 6 - 6
Medicine use high among children and adolescents worldwide Clinical study 10 February 2013 Pages: 6 - 6
Modest BP changes greatly affect CV risk, cost burden in OA, RA News item 10 February 2013 Pages: 7 - 7
PEG IFN-α-2b + weight-based ribavirin best value in hep C Clinical study 10 February 2013 Pages: 7 - 7
Electronic reminders improve adherence to HIV guidelines Clinical study 10 February 2013 Pages: 8 - 8
Lithium to valproic acid prescribing shift in the elderly lacks evidence Clinical study 10 February 2013 Pages: 8 - 8
Barriers to ADHD diagnosis, treatment in ethnic minorities in the US Media release 10 February 2013 Pages: 9 - 9
Quality, not just quantity, of antibacterial prescribing needs improving Clinical study 10 February 2013 Pages: 10 - 10
Iraqi health system needs funding boost for damage control Media release 10 February 2013 Pages: 11 - 11
Leukotriene antagonists limited to control allergy use in US News item 10 February 2013 Pages: 11 - 11